A cheap, accessible test that can help with diabetes clinical care is C-peptide measurement, especially for individuals who are not on insulin and whose response to oral anti-diabetic drugs is unsatisfactory. SGLT-2 inhibitors should be preferred over other anti-diabetic drugs as an add-on to existing metformin therapy. This evidence concerns the gene SLC5A2 and diabetes mellitus.